Anaphylaxis Update: Strategies for Diagnosis, Prevention, and Treatment Enduring Activities
Eli O. Meltzer, MD
Phil Lieberman, MD
Supported by an
Minimum System Requirements
Windows XP, Windows 2000, Windows Vista, and Windows 7 Intel Pentium 4, 2.33 + GHz (or equivalent)
Mac OS X v10.4 or later
With recent estimates suggesting that there has been a rise in allergic reactions, especially in children and adolescents, it has become critically important that healthcare providers are armed with the most up-to-date information on the diagnosis, prevention, and treatment of anaphylaxis. In the United States, an emegency department visit for anaphylaxis from food occurs every 6 minutes and anaphylaxis from food ingestion or insect stings causes 40 to 200 deaths per year.
Despite substantial progress in the field of anaphylaxis, and recently updated practice guidelines, many clinical questions remain. An improved understanding of recommended management strategies can prevent urgent care or emergency department visits and reduce the morbidity and mortality associated with anaphylaxis. There is a critical need to align practice standards across the healthcare settings, so that prevention and treatment goals are met in the care of patients with anaphylaxis.
These activities will review the essentials of anaphylaxis management to ensure that optimal care is given to patients who are at risk.
This activity has been designed to meet the educational needs of emergency medicine physicians, pediatricians, nurse practitioners, physician assistants, and other healthcare providers involved in the care of patients with anaphylaxis.
Learning ObjectivesUpon completion of this educational activity, participants should be able to:
Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education to physicians.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest
Integrity Continuing Education, Inc. requires instructors, planners, managers, and other individuals who are in a position to control the content of these activities to disclose any real or apparent conflicts of interest they may have as related to the content of these activities. All identified conflicts of interest are thoroughly vetted by Integrity Continuing Education, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The faculty/planners reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of these CME activities:
Phil Lieberman, MD
Eli O. Meltzer, MD
Sean Gregory, PhD
Directions to the Learner
There are no fees for participating and receiving CME credit for this activity.
A statement of credit will be issued only upon receipt of a completed posttest with a score of 70% or better and a completed evaluation form. Your statement of credit will be mailed to you within 4 weeks.
Disclosure of Unlabeled Use
These educational activities may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integrity Continuing Education, Inc. and Mylan Specialty do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in these educational activities are those of the faculty and do not necessarily represent the views of Integrity Continuing Education, Inc. and Mylan Specialty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in these activities is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Please note: only 1 activity may be completed for credit. Double credit will not be issued for completing both activities.